医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Ornithine Laboratory: Longevity Superpower – Japan’s 70 Year-Olds Battling in 100m Race Captured in a Video Release

2012年11月06日 AM12:25
このエントリーをはてなブックマークに追加

Smart Multimedia Gallery

 

Left: Kageki Shimoda; Right: Pe Hayashiya (Photo: Business Wire)Left: Kageki Shimoda; Right: Pe Hayashiya (Photo: Business Wire)

View and Share Photo

Close Window


TOKYO

On Wednesday October 24, 2012, the Ornithine Laboratory has made a new video available to the public on its website for the ‘Japan Otsukare University, Faculty of Ornithine’ (literally University of Fatigue, Faculty of Ornithine – http://www.otsukare-univ.jp/). The site was established for the fictional university, with a goal of ‘eliminating fatigue in the world’.
This video depicts a showdown between Kageki Shimoda and Pe Hayashiya in a powerful, colorful 100-meter dash like never before seen. Shimoda is a holder of one of the most prestigious literary awards in Japan – the Naoki Prize. Hayashiya is a comic-chat artist, one of Japan’s historic traditional arts.

Left: Kageki Shimoda; Right: Pe Hayashiya (Photo: Business Wire)

Left: Kageki Shimoda; Right: Pe Hayashiya (Photo: Business Wire)

At the site (available in Japanese only) Shimoda plays the ‘tireless’ character; a school principal who combines radical fashion sense belying his age of 72 years, and intelligence. His challenger is 70 year-old Pe Hayashiya, a comedian known for his trademark pink outfits.

In this clip, you can watch the couple running the 100-meter race and navigating over jump-ropes. Take a moment and enjoy the video.

About the Ornithine Laboratory

The Ornithine Laboratory was established on October 28, 2009 as a non-profit scientific organization whose purpose is to educate and build global attention to ‘ornithine’. Ornithine is a type of free-amino-acid found in freshwater clams.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50462314&lang=en

CONTACT

Ornithine Laboratory
Natsumi Hayabuchi/Yoshiharu Asao,
+81-3-5770-6005 (available in Japanese only)
Public relations
office (in Integrate Co., Ltd)
press@ornithine.jp

同じカテゴリーの記事 

  • ENHERTU® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in HR Positive, HER2 Low Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy in DESTINY-Breast06 Phase 3 Trial
  • PROTEINA Initiates Global Clinical Validation Project with Emory University School of Medicine, USA
  • AriBio 获得欧洲药品管理局对AR1001治疗阿尔茨海默病3期临床试验(POLARIS-AD)的授权
  • AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer’s Disease (POLARIS-AD)
  • ReNAgadeセラピューティクス、GanNA Bioと糖鎖生物学に対するコミットメントを継続